Genome Engineering Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Genome Engineering Market – By Delivery Mode (Ex-vivo, In-vivo), By Technology (CRISPR, ZFN, TALEN), By Application (Animal/Plant Cell Editing), By End-use and Segment Forecasts from 2021 to 2027

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The Global Genome Engineering Market is anticipated to grow from USD 5.1 billion to USD 11.2 billion till the forecasting year 2027 and grow at a CAGR of 17.0% during the period of forecast 2021-2027. Genome editing is a technique for making precise alterations to a cell’s or organism’s DNA. It is used to change DNA with a cell in a precise and efficient manner. Genome editing entails using enzymes known as designed nucleases to cut specific DNA sequences. Genome editing can also be used to remove, add, or change DNA in the genome, and it is commonly employed in research and treatment. AIDS, leukaemia, and numerous viral and genetic illnesses are among the therapy conditions. Gene editing is another name for genome engineering. Homologous recombination is anticipated to be utilized as an efficient technology for crop improvement. Increase in the number of genomics projects and government funding facilities will drive the market growth. High price of genome engineering therapies is anticipated to hit the growth of genome engineering market during the forecast period particularly in rising countries such as South Africa, India and Brazil. This therapy involves using a complex technology and requires expert researchers, which in turn limit the market growth. Several notable development are observed in the genome engineering market as companies have adopted crucial strategies like collaboration, partnership, agreement and acquisition. Key players have also adopted some crucial strategies like approvals, product expansion and product launch, which allows them to maintain their position in the market and also increase their overall customer base. Growth factors driving the genome editing market in upcoming days are increase in funds by government in different regions, government support for the academic institutes to increase research activities for genome editing and huge increase in funding. Increasing cancer cases, growth of pharmaceutical companies, fast advancements and increase in public sector funding are some significant factors boost the genome engineering market.


Genome Engineering Market

MARKET SUMMARY
-
17.0%
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 17.0%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Genome Engineering Market

  • There are many prominent elements that contribute in driving the genome engineering market such as increasing occurrence of genetic disorders, increasing number of genetically modified crops production, increasing developments for genome engineering therapy and rise in funding for genome engineering.
  • The genome engineering market is increasing hugely due to the use of genome technique in several different areas like agriculture biotechnology, mutation and therapeutics. Increase in the number of sicknesses and applications of genome editing lead towards increasing the scope for genome engineering in upcoming years.
  • A few factors contribute to restrain the market growth such as stringent regulation and the perception of the people for genetic alteration. Genome editing therapies provide a huge range of opportunities in crop investment. Homologous recombination is anticipated to be utilized as an efficient technology for crop improvement. Increase in the number of genomics projects and government funding facilities will drive the market growth.
  • High price of genome engineering therapies is anticipated to hit the growth of genome engineering market during the forecast period particularly in rising countries such as South Africa, India and Brazil. This therapy involves using a complex technology and requires expert researchers, which in turn limit the market growth
Market Key Players
  • CRISPR Therapeutics,
  • Thermo Fisher Scientific
  • GenScript Corporation
  • Sangamo Therapeutics, Inc
  • Horizon Discovery Group
  • Integrated DNA Technologies
  • New England Biolabs
  • OriGene Technologies
  • Lonza Group
  • Editas Medicine
Growth

Genome Engineering Market

Genome engineering is a therapy used for the modification, insertion and deletion of DNA bases in living being. Ex-Vivo Gene and In-Vivo Gene are the two kinds of therapies available. The aim behind doing genome engineering is to treat different diseases and doing research. It is also used for biotechnological purpose too. This therapy is also used for cutting DNA chains to add or remove the DNA in the genome. Important techniques employed in genome engineering include ZFN, CRISPR and TALEN. Such effective genome engineering tools greatly help researchers for editing parts of the genome with adding, removing and changing the sections of the DNA sequence. CRISPR is an affordable, rapid and precise tool used rather than other tools to edit DNA. Genome engineering therapy involves understanding the role of particular genes. This therapy also involves understanding the processes of organ specific stem cells like stem cells like spermatogonial stem cells and neutral stem cells. Different types of cancers, Agents of infectious sicknesses like parasites, viruses, bacteria and genetically affected cells are treated with genome editing.


North-America Got Significant Share

Genome Engineering Market

North America, closely followed by Europe, leads the global genome editing/genome engineering market. Market expansion in North America is being fueled by factors such as the development of gene therapy in the United States, the increased use of genetically modified crops, the rising prevalence of infectious diseases and cancer, and the availability of research grants and financing.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015 to 2020) and forecast (2021 to 2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Genome Engineering Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • CRISPR Therapeutics,
  • Thermo Fisher Scientific
  • GenScript Corporation
  • Sangamo Therapeutics, Inc
  • Horizon Discovery Group
  • Integrated DNA Technologies
  • New England Biolabs
  • OriGene Technologies
  • Lonza Group
  • Editas Medicine

Description

The Global Genome Engineering Market is anticipated to grow from USD 5.1 billion to USD 11.2 billion till the forecasting year 2027 and grow at a CAGR of 17.0% during the period of forecast 2021-2027. Genome editing is a technique for making precise alterations to a cell’s or organism’s DNA. It is used to change DNA with a cell in a precise and efficient manner. Genome editing entails using enzymes known as designed nucleases to cut specific DNA sequences. Genome editing can also be used to remove, add, or change DNA in the genome, and it is commonly employed in research and treatment. AIDS, leukaemia, and numerous viral and genetic illnesses are among the therapy conditions. Gene editing is another name for genome engineering. Homologous recombination is anticipated to be utilized as an efficient technology for crop improvement. Increase in the number of genomics projects and government funding facilities will drive the market growth. High price of genome engineering therapies is anticipated to hit the growth of genome engineering market during the forecast period particularly in rising countries such as South Africa, India and Brazil. This therapy involves using a complex technology and requires expert researchers, which in turn limit the market growth. Several notable development are observed in the genome engineering market as companies have adopted crucial strategies like collaboration, partnership, agreement and acquisition. Key players have also adopted some crucial strategies like approvals, product expansion and product launch, which allows them to maintain their position in the market and also increase their overall customer base. Growth factors driving the genome editing market in upcoming days are increase in funds by government in different regions, government support for the academic institutes to increase research activities for genome editing and huge increase in funding. Increasing cancer cases, growth of pharmaceutical companies, fast advancements and increase in public sector funding are some significant factors boost the genome engineering market.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX